Technical Notes on Endoscopic Transnasal Transsphenoidal Approach for Clival Chondrosarcoma by Kuge, Atsushi et al.
Hindawi Publishing Corporation
Sarcoma
Volume 2011, Article ID 953047, 6 pages
doi:10.1155/2011/953047
Methodology Report
TechnicalNotes onEndoscopic TransnasalTranssphenoidal
Approach for ClivalChondrosarcoma
AtsushiKuge,1 ShinyaSato,1 KaoriSakurada,1 SunaoTakemura,1 Zensho Kikuchi,1
Yuki Saito,1 and TakamasaKayama1,2
1Department of Neurosurgery, Yamagata University Faculty of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan
2National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
Correspondence should be addressed to Atsushi Kuge, akuge@med.id.yamagata-u.ac.jp
Received 30 August 2010; Revised 11 January 2011; Accepted 17 January 2011
Academic Editor: Jose Casanova
Copyright © 2011 Atsushi Kuge et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Although there are various operative approaches for clival tumors, a transsphenoidal approach is one of choices when the main
tumor extention is in an anterior-posterior direction with a slight lateral extension. However, this approach sometimes provides
only narrow and deep operative ﬁeld. Recently, endoscopic transnasaltranssphenoidal approach is quite an eﬀective approach for
clivaltumorsbecauseoftheimprovementofsurgicalinstruments,imageguidancesystems,andtechniques andmaterialsofwound
closure. In this paper, we describe the eﬀectiveness, technical problems, and solution of this approach based on our experiences
with two clival chondrosarcomas that was removed by endoscopic transnasaltranssphenoidal approach.
1.Introduction
Clival chondrosarcomas are rare group that are thought
to originate from primitive mesenchymal cells or from the
embryonal portion of the cartilaginous matrix of the cra-
nium. And these tumors have aggressive features, inﬁltrative
neoplasms. Although it is generally agreed that surgery is the
choice of treatment for clival chondromas and chodrosar-
comas, it is still controvertial whether it is preferable to
attempt a radical resection, which implies wide exposure,
extensive dissection, and the potential for signiﬁcant surgical
morbidity, or to determine the oncological features of
the tumors and plan local control through more limited
approaches.Transbasal,transmaxillary, transoral,transfacial,
and subtemporal approaches have been used for clival lesion
[1–5].
On the other hand, transsphenoidal approach [6, 7]w a s
used from 1960s [8], this approach was not widely spread
becauseofnarrowanddeepoperativeﬁeldusingmicroscope,
and diﬃculty of wound closure complicated cerebrospinal
ﬂuid leakage [7]. However, an endoscopic transsphenoid-
al approach is now quite an eﬀective approach for clival
tumors because of the improvement of surgical instruments,
image guidance systems, and materials of wound closure
such as ﬁbrin glue. In this paper, we describe the eﬀec-
tiveness, technical problems and solution of this approach
based on our experiences with two clival chondrosarcomas
that was removed by endoscopic transnasal transsphenoidal
approach.
2.Patientsand Methods
Consecutive two patients with a clival chondrosarcoma
treated using an endonasal endoscopic approach were iden-
tiﬁed [9]. In all cases, frameless neurosurgical navigation
(VectorVision: Brain LAB Co., Ltd.) was used.
Case1. Aﬁfty-six-year -oldmalewassuﬀeringfromdiplopia.
He showed left abducens nerve palsy, and MRI revealed
clival enhanced mass lesion extending toward brainstem and
cavernoussinus. First surgery was performed by craniotomy,
and tumor was resected partially and get decompression
of brainstem. Immunohistochemically, vimentin was posi-
tive, epithelial membrane antigen (EMA) and cytokeratin2 Sarcoma
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Figure 1: An original long navigation pointer (a) registered by the Universal Instrument Integration system ((b): VectorVision: BrainLAB
Co.,Ltd.).Longandsliminstrumentsweused forthisoperation,highspeed drill((c):Primado:NakanishiCo., Ltd.)andultrasonicaspirator
((d): SONOPET: M&M Co., Ltd.).
Figure 2:Case1. Upper: MRI images 33 monthsafter the ﬁrst operation. The residual tumoris regrowing. Lower: MRI imagesafter surgery,
midline part of tumor was resected and decompressed brainstem.
(CAM5.2) were negative, and pathological diagnosis was
chondrosarcoma. Thirty-three months after ﬁrst surgery,
tumor enlargement was conﬁrmed. Second surgery was per-
formed by endoscopic transnasal transsphenoidal approach
because tumor was mainly extended toward the posterior
part. We used an endoscope with long axis (180mm) and
angled tip (0, 30, 70 degrees: HOPKINSII: KARL STORZ
Co., Ltd.). And we made special navigation probe to get
more correct information. It was registered by Universal
Instrument Integration System (VectorVision: BrainLABSarcoma 3
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Figure 3: Case 2. Upper: MRI images after the second operation. Lower: MRI after transsphenoidal surgery. Tumor was resected except
suprasellar part and decompressed brainstem.
CO., Ltd.) which could make favorite length of navigation
probe using materials you like. And instruments which long
and slim curettes (Zonne Co., Ltd.), ultrasonic aspirator
probe developed for abdominal surgery (SONOPET: M&M
Co., Ltd.), high-speed drill (Primado: Nakanishi Co., Ltd.)
which have curved handle did not to disturb operative ﬁeld
without the interference of each tools (Figure 1). We could
get resection of main part of tumor without cavernous
lesions. Dural defect was observed, and it was repaired by
ﬁlling sphenoid sinus by autologousfat and ﬁbrin glue. After
surgery, new neurological deﬁcit and cerebrospinal ﬂuid
leakage were not seen. Residual tumor regrowth was not
observed for ﬁfty months after surgery (Figure 2).
Case 2. A thirty-six-year-old male presented right motor
weakness, diplopia, and facial sensory disturbance because
of its oculomotor, trochlear, and trigeminal nerve impair-
ment. CT and MRI showed enhanced mass lesion with
calciﬁcation located clivus, and it extended toward brain-
stem and its lateral side. The ﬁrst surgery was performed
by craniotomy, and tumor was resected partially. Thirty
months after surgery, residual tumor regrowth was detected.
And a second transcranial surgery was performed. After
the second surgery, cranial nerve palsy gradually improved.
But ﬁfty months after the second surgery, the tumor was
growing toward brainstem and sphenoid sinus. The third
surgery was performed by endoscopic endonasal transsphe-
noidal approach, because main part of tumor extension
was midline. We performed the surgery with the same
strategy as Case 1, that was using instruments that do
not disturb the operative ﬁeld without the interference by
transphenoidalapproach.Wemadesuprasellarpartoftumor
remain intentionally, because suprasellar part was very hard,
and we considered the possibility of the involvement of
perforators and injury of hypothalamus. We could perform
precise manipulation without intraoperative complications
such as carotid artery and basilar artery, cranial nerves, and
brainstem injuries. This case was also seen dural defect, and
it was repaired by patched with muscle fascia at defect and
ﬁlling sphenoid sinus by autologousfat and ﬁbrin glue. After
surgery, there were no new deﬁcit and cerebrospinal ﬂuid
leakage. Immunohistochemically, epithelial membrane anti-
gen(EMA)and cytokeratin(CAM5.2)were negative,andthe
pathological diagnosis was chondrosarcoma. Residual tumor
regrowth was not observed for thirty months after surgery
(Figures 3, 4 and 5).4 Sarcoma
Figure 4: Case 2. Intraoperative endoscopic view. Upper left: tumor capsule extending sphenoid sinus (asterisk), right: bilateral carotid
prominence and expose carotid artery (triangle), lower left: lateral part of the lesion (star). Endoscope with long axis gave us clear operative
view but diﬃcult to reach surgical instruments and intratumoralmanipulation.Lower right: We could observe the surface of brainstem and
basilar artery through dural defect. basilar artery (square), brainstem (circle).
3.Discussion
Although there are various operative approaches for clival
tumors [1–5], a transsphenoidal approach [6, 7]i so n eo f
choices when the main tumor extention is in an anterior-
posterior direction with a slight lateral extension.
Bouche et al. [8] reported transsphenoidal approach
for clival tumor in 1966, but in those days, there was the
limitation of removal of tumor which extend to lateral
and deep part, because it is diﬃcult to obtain suﬃcient
microscopicoperativeview. Asaresult,thisapproach didnot
widely spread.
Recently, development of neuroendoscope gives us
improvements of visibility of operative ﬁeld. And innova-
tion of surgical instruments that specialized in endoscopic
transsphenoidal approach and image navigation systems
gives us safe and precise surgical procedures [10].
However, this approach sometimes provides only narrow
and deep operative ﬁeld. To remove the tumor which
requires us to progress more into deeper and lateral parts,
we have to use longer endoscope to observe details and
instruments could be reached to those parts. Rhoton Jr.
[11] described dissection instruments have shafts at least
120mm in length when reach intrasuprasellar lesion for
transspnenoidal surgery. When we consider the interference
of bimanual manipulation and the surgical instruments
inside and outside of the nasal cavity, we think that more
longer endoscope and surgical instruments seems to be
needed for clival lesion especially extend superior-posterior
part.
In our case, we used endoscope with long axis (length:
180mm) and angled tip (0, 30, and 70 degrees, HOPKINSII:
KARL STORZ Co., Ltd.) that was able to observe deep
operative ﬁeld, superior and lateral part of lesion. And
instruments which have long and slim curettes, ultrasonic
aspirator probe for abdominal surgery, and high-speed drill
which have curved handle were not to disturb operative ﬁeld
withouttheinterference ofeachtool.These instrumentsgave
us easy and precise manipulation of tumor removal. When
we used neuronavigation system, we made our own long
probe to navigate the deep part. And this information might
make us avoid intraoperative complications of parasellar
critical structures.
Cerebrospinal ﬂuid leakage is a major complication of
transsphenoidal surgery, and it is an important factor to
get good results of this surgery. Frank et al. [12]r e p o r t e dSarcoma 5
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that they experienced 18% CSF leakages after endoscopic
transsphenoidal surgery. And CSF leakages were controlled
by fat packing. To prevent this complication, we do re-
construction by fat packing, dural plasty using muscular
fascia, pedicled nasoseptal ﬂap, and ﬁbrin glue. And these
techniques were applied to parasellar lesion such as clival
chondrosarcoma.
Almefty et al. [13] mentioned that chordoma and
chondrosarcoma diﬀered with regard to their origin and
histology and diﬀered markedly with regard to outcome.
That is, chordoma type (chordoma and chondroid chor-
doma) demonstrated aggressive clinical course and poor
outcome. On the other hand, chondrosarcoma patients had
a signiﬁcantly better outcome compared with chordoma
patients with regard to survival and recurrence-free survival
without high-dose radiotherapy. Almefty et al. mentioned
that radiotherapy may not be necessary in patients with low-
grade chondrosarcoma. Our cases were diagnosed low-grade
chondrosarcoma, and their features were consistent with the
concept of Almefty et al. group.
Recently, radiotherapy such as heavy ion irradiation
develops as an additional treatment for clival tumors [9].
While less invasive surgical approach would be recom-
mended, it might be one of a choice as a strategy for clival
tumors, that is, a combination of subtotal resection and
radiotherapy such as heavy ion irradiation for residual lesion
to avoid complications of parasellar critical structures.
However, there are still insuﬃcient measures for progres-
sion into deep and lateral parts, even if using our surgical
instruments as the above. Especially, we need development
of surgical instrument to reach the lateral part of the
lesion. Further development and improvement of special
instruments for transsphenoidal approach will be needed for
clival tumors such as chondrosarcoma.
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